AntonioDi StasiMD(he/him)

Associate Professor of Medicine

Dr. Di Stasi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

I received an M.D. degree from the University of Modena in Italy, and peformed internal medicine and medical oncology training at the university of Milan, in Italy, focusing on the management of hematologic malignancies and hematopoietic stem cell transplantation. Afterwards I joined the Center for Cell and Gene Therapy (Baylor College of Medicine, Houston, TX) for post-doctoral studies, and the University of Texas MD Anderson Cancer Center for Bone Marrow Transplantation fellowship and clinical research. Currently I am physician-scientist at UAB, Birmingham AL, in the BMT& Cell Therapy Program.

PubMed

166 citations
Inducible caspase-9 suicide gene controls adverse effects from alloreplete T cells after haploidentical stem cell transplantation
Xiaoou Zhou, Gianpietro Dotti, Robert A. Krance, Caridad Martinez, Swati Naik
Blood. 2015-06-25
720 citations
Gilteritinib or chemotherapy for relapsed or refractory FLT3-mutated AML
Alexander E. Perl, Giovanni Martinelli, Jorge E. Cortes, Andreas Neubauer, Ellin Berman
The New England Journal of Medicine. 2019-10-30
418 citations
T lymphocytes coexpressing CCR4 and a chimeric antigen receptor targeting CD30 have improved homing and antitumor activity in a Hodgkin tumor model.
Antonio Di Stasi, Biagio De Angelis, Cliona M. Rooney, Lan Zhang, Aruna Mahendravada
Blood. 2009-06-18

Books/Book Chapters

Cancer: Expert, Clinical Perspectives
Chapter: Hematopoietic cell transplantation in myelodisplastic syndromes
Page 126 - 130Di Stasi A, Ghobadi A, Kebriaei PEditors: Abutalib, Markman.Wiley&SonsEdition 1,2014
Oncologia.
Chapter: Cure Palliative e Riferimenti Online
Di Stasi AEditors: Mercadante S, Ripamonti C.Masson
Libro Italiano di Cure Palliative.
Chapter: Oppioidi
Ripamonti C, Di Stasi AEditors: Amadori S, De Conno F.Poletti

Abstracts/Posters

A Phase II Clinical Trial of Post-Transplant Cyclophosphamide for Graft Versus Host Disease Prevention Following Myeloablative Peripheral Blood Stem Cell Matched Unrel...
Antonio Di Stasi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019